Drug intelligence / Profile preview

embryonic stem cell-derived mesenchymal stem cells

Development stage
Preclinical
Lead developer
Daewoong Pharmaceutical
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intra-arterial
01

Overview

Embryonic stem cell-derived mesenchymal stem cells (ES-MSCs) are a specialized population of mesenchymal stem cells generated from human embryonic stem cell (hESC) lines. They are being investigated as a therapeutic platform for neurodegenerative diseases, most notably Alzheimer's disease (AD). Preclinical studies indicate that ES-MSCs can reduce the accumulation of amyloid-beta (Aβ) in the brain by enhancing autophagolysosomal clearance mechanisms. Additionally, these cells demonstrate superior viability and neuroprotective capacity compared to traditional bone marrow-derived MSCs (BM-MSCs) in amyloid-rich environments. Clinical interest in ES-MSCs stems from their potential for large-scale production and their ability to improve cognitive function and inhibit hippocampal cell death when administered via intra-arterial or other systemic routes.

Other names
hES-MSCshuman embryonic stem cell-derived mesenchymal stem cellsESC-MSCs

Beyond the preview

Go deeper on embryonic stem cell-derived mesenchymal stem cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on embryonic stem cell-derived mesenchymal stem cells.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call